TWST
Twist Bioscience Corp
2 of the 83 super-investors we track hold TWST, worth a combined $94M per their latest 13F filings. The largest position: Joel Greenblatt at 0.1% of their portfolio. This quarter the cohort logged 0 buys and 1 sell on the name. Conviction score: 14 of 100 (how strongly the cohort backs it) — ranked #722 of 742 stocks. Conviction easing: 1 fewer super-investor hold it than in 2026Q1.
Why super-investors own TWST
TWST is held by 2 super-investors in our cohort, with a combined position value of $94M. The highest-conviction owner is Joel Greenblatt at 0.1% of their portfolio. Cohort ownership has grown from 1 to 2 over the last four quarters — net interest is rising. This quarter the cohort registered 1 exited.
AI-synthesized from 13F filings. Not investment advice.
Cohort owners over time
2019Q3 → 2026Q2How many of the cohort members held this stock each quarter.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Joel Greenblatt | 0.1% | 27q | $89M | 862,042 |
| 2 | Polen Capital Management | <0.1% | 2q | $6M | 55,310 |
Owners of TWST also hold
Congress is trading TWST
Congress tracker →- Dwight Evanssold$1,001 - $15,000 · 2022-03-30
- Dwight Evansbought$1,001 - $15,000 · 2020-03-02 · late
STOCK Act periodic transaction reports; amounts are disclosed ranges. Who files late →
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller | EXIT | 0.3% | -100% | $0 | Aug 14, 2026 |
Long US equity 13F-HR filings only. CUSIP 90184D100. Not investment advice.